Foot and Mouth Disease Vaccines Market Size & Share 2024 - 2032

Foot and Mouth Disease Vaccines Market Size

Foot And Mouth Disease Vaccines Market size was valued at USD 2.5 billion in 2023 and is anticipated to witness growth at a CAGR of 7.7% between 2024 and 2032. The FMD vaccines market is experiencing growth driven by the rising prevalence of foot and mouth disease outbreaks, active involvement of government authorities, and substantial commercialization of livestock products.

Foot and Mouth Disease (FMD) is a highly contagious viral infection affecting animals such as pigs, cattle, goats, and sheep. The virus belongs to the Picornaviridae family and manifests with symptoms including fever and blisters in the mouth, on the feet, and sometimes on the teats. The substantial prevalence of FMD across the world is a prominent factor accelerating the growth of the market. For instance, according to data published by the World Organization for Animal Health in 2023, the foot and mouth disease virus circulates in an estimated 77% of the global livestock population in regions such as Africa, the Middle East, Asia, and South America. This significant prevalence of the disease is likely to boost routine vaccinations, which will eventually accelerate market growth by 2032.
 

In addition, strategic steps taken by government authorities are expected to further propel the growth of the FMD vaccines market during the forecast period. For instance, in July 2023, the government of Canada announced its plan to develop a full-fledged vaccine bank for foot and mouth disease in livestock. Moreover, in May 2023, the World Bank approved a loan of USD 82 million to support the adoption of global best practices in animal health management for the government of India.
 

Foot and mouth disease vaccines in animals are immunizations designed to protect livestock such as cattle, goats, pigs, sheep, and other cloven-hoofed animals from the highly contagious viral disease caused by the foot and mouth disease virus (FMDV). These vaccines contain inactivated or attenuated strains of the virus, which stimulate the animal's immune system to produce antibodies without causing the disease.
 

Foot and Mouth Disease Vaccines Market Trends

• Governments worldwide are undertaking various initiatives to enhance foot and mouth disease (FMD) vaccination programs, recognizing the significant impact of FMD on livestock health, agricultural productivity, and economic stability.
   
• These initiatives focus on improving vaccine accessibility, ensuring comprehensive immunization coverage, and fostering international collaboration to control and eventually eradicate FMD. For instance, in August 2022, the government of Queensland approved USD 20 million to bolster defense strategies against foot and mouth disease in the region.
   
• Many governments provide financial support and subsidies to reduce the cost burden of FMD vaccines for farmers. By subsidizing vaccine costs, governments make vaccination more affordable and encourage widespread adoption among livestock owners. For example, in India, the government launched the National Animal Disease Control Program (NADCP), which aims to vaccinate 100% of the country's cattle, sheep, pigs, buffalo, and goats against FMD.
   
• Organized vaccination campaigns are a crucial part of government initiatives. These campaigns are often conducted in collaboration with veterinary services and agricultural departments to ensure systematic and timely vaccination of livestock. For instance, in April 2024, the government of Brazil conducted a nationwide foot and mouth disease vaccination campaign with the aim of combating potential FMD outbreaks. The government plans to make the country FMD-free by 2026.
   
• Raising awareness about the importance of FMD vaccination is another critical focus area. Governments run educational programs and workshops for farmers, veterinarians, and other stakeholders to inform them about the benefits of vaccination, proper vaccination techniques, and the risks associated with FMD outbreaks.
   
• Effective surveillance systems are essential for tracking FMD outbreaks and assessing the effectiveness of vaccination programs. Governments invest in strengthening disease monitoring networks, enhancing diagnostic capabilities, and establishing reporting mechanisms to detect and respond to FMD cases promptly.
   

Foot and Mouth Disease Vaccines Market Analysis

Based on vaccine type, the market is segmented into conventional vaccines and emergency vaccines. The conventional vaccines segment is further sub-segmented into aluminium hydroxide & saponin-based and oil-based vaccines. In 2023, the conventional vaccines segment held a dominant market share of 83.9%.
 

• The high demand for conventional FMD vaccines is driven by several critical factors. FMD is a highly contagious viral disease affecting cloven-hoofed animals, leading to significant economic losses in the livestock industry due to decreased productivity, trade restrictions, and the need for extensive control measures. Conventional vaccines, primarily inactivated vaccines, have long been the cornerstone of FMD prevention and control.
   
• These vaccines have a proven track record of success in various regions, particularly in endemic areas where the disease poses a constant threat. Their effectiveness in preventing outbreaks and reducing the severity of the disease in vaccinated animals has been well-documented.
   
• Additionally, the expanding international trade of livestock and animal products necessitates stringent disease control measures. Compliance with international trade regulations and standards set by bodies like the World Organization for Animal Health (OIE) drives the demand for reliable and widely accepted conventional FMD vaccines.
   

Based on the type of animal, the foot and mouth disease vaccines market is classified into cattle, sheep & goats, pigs, and other animals. The cattle segment accounted for the highest market share, valued at USD 1.4 billion in 2023.
 

• Cattle are highly susceptible to FMD and are considered one of the primary hosts for the virus. They often experience severe clinical symptoms, including fever, lameness, drooling, and the formation of characteristic vesicles on the feet, mouth, and teats.
   
• Additionally, the large global population of cattle contributes significantly to the demand for FMD vaccines. Cattle are bred and raised in various regions worldwide, encompassing both developed and developing countries. The diverse geographical distribution of cattle populations underscores the need for widespread vaccination efforts to control and prevent FMD outbreaks on a global scale.

Learn more about the key segments shaping this market

Download Free PDF

Based on distribution channel, the foot and mouth disease vaccines market is categorized into veterinary hospitals & clinics, government institutions, retail pharmacies, and online pharmacies. The veterinary hospitals & clinics segment is projected to reach USD 1.2 billion by 2032.
 

• The majority of foot and mouth disease vaccine distribution occurs through veterinary hospitals and clinics due to their central role in animal healthcare and disease management. These facilities serve as primary points of contact for livestock owners seeking veterinary services, including vaccinations.
   
• Veterinary professionals at hospitals and clinics are equipped with the knowledge, expertise, and infrastructure to administer FMD vaccines effectively and safely.
   
• Additionally, these establishments often maintain stockpiles of vaccines, ensuring timely availability and accessibility for livestock farmers. As trusted sources of veterinary care, hospitals and clinics play a pivotal role in facilitating the widespread distribution and adoption of FMD vaccines within the agricultural community.

The North America foot and mouth disease vaccines market was valued at USD 703.4 million in 2023 and is predicted to grow at a CAGR of 6.7% over the analysis timeframe. The region held a considerable share of the market.
 

• The increasing adoption of foot and mouth disease (FMD) vaccines in North America signifies a proactive approach towards safeguarding livestock and the agricultural industry against this highly contagious viral infection. Recognizing the devastating impact of FMD outbreaks on livestock populations and the agricultural economy, there is a growing emphasis on preventive measures. Vaccination is a key component of FMD control programs, aimed at reducing the risk of infection and limiting the spread of the virus.
   
• North America's participation in the global livestock trade necessitates adherence to international standards for disease control, including FMD prevention. The adoption of vaccines helps maintain the region's reputation as a reliable supplier of livestock and livestock products, ensuring access to international markets without facing trade barriers.
   

The U.S. foot and mouth disease vaccines market is anticipated to grow at a CAGR of 6.7% to reach USD 1.3 billion by 2032.
 

• The considerable prevalence of foot and mouth disease in the country is a major driver of market growth. FMD outbreaks have the potential to inflict substantial economic losses, disrupt supply chains, and compromise food safety. By proactively vaccinating livestock herds, the U.S. enhances its preparedness and resilience against FMD incursions, minimizing the socio-economic impact of potential outbreaks on both the agricultural industry and the broader economy.
   
• Additionally, technological advancements and government approvals for new technologies are expected to boost the adoption of foot and mouth disease vaccines in the country. For instance, in February 2023, the U.S. Department of Agriculture announced its plan to procure advanced diagnostic kits for the detection of foot and mouth disease.
   

The UK foot and mouth disease vaccines market is projected to grow remarkably in the coming years.
 

• The UK livestock industry recognizes the critical importance of robust biosecurity measures in safeguarding against infectious diseases like FMD. With the increasing globalization of trade and the heightened risk of disease incursions, there is a growing emphasis on vaccination as a proactive measure to bolster the resilience of livestock herds and protect against potential outbreaks.
   
• Additionally, the UK's adoption of FMD vaccines is driven by the desire to stay ahead of emerging disease threats, ensuring the timely availability of effective vaccines to protect vulnerable livestock populations.
   

China is experiencing high growth in the foot and mouth disease vaccines market.
 

• The growth of China's market is largely attributed to active government involvement in livestock care, awareness programs, and subsidies for vaccination programs. The adoption of FMD vaccines is motivated by a desire to minimize economic losses and safeguard the stability of the livestock sector.
   
• Moreover, China is witnessing extensive investments in research and development activities for vaccine innovations. The availability of next-generation vaccines enhances the feasibility and effectiveness of FMD vaccination programs in China.
   

Foot and Mouth Disease Vaccines Market Share

The market industry is characterized by the presence of several established and emerging players that offer a variety of treatments across the globe. The market players compete based on factors such as treatment quality, innovation, regulatory compliance, customer service, and pricing strategies.
 

Foot and Mouth Disease Vaccines Market Companies

Prominent players operating in the market industry include:

• Biogénesis Bagó
• Biovet Private Ltd
• Brilliant Bio Pharma Private Limited
• BVI
• C.H. Boehringer Sohn AG & Co. KG
• Ceva Santé Animale
• Indian Immunologicals Ltd.
• Inner Mongolia Biwei Antai Biotechnology Co., Ltd.
• Kenya Veterinary Vaccines Production Institute 
• Merck & Co., Inc.
• MEVAC
   

Foot and Mouth Disease Vaccine Industry News:

• In November 2023, Biogénesis Bagó received EuFMD approval for its BIOAFTOGEN foot and mouth disease vaccine. This approval allows the company to market and distribute its vaccine in Europe.
   
• In October 2022, the government of Indonesia received 3 million doses of foot and mouth disease vaccine from Australia, aimed at managing the impact of the FMD outbreak in the country.
   

The foot and mouth disease vaccines market research report include an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 - 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Vaccine Type

• Conventional vaccines
  • Aluminium hydroxide & saponin-based vaccines
  • Oil-based vaccines
• Emergency vaccines

Market, By Animal Type

• Cattle
• Sheep & goat
• Pig
• Other animals

Market, By Distribution Channel

• Veterinary hospitals & clinics
• Government institutions
• Retail pharmacies
• Online pharmacies

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa